Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • MNST vs MRNA✓SelectedUSD · MRNAMNST vs MRNA performance historyLatest closeAs of-2.16%11/19
Stock and ETF performance explorer

MNST vs MRNA

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+60.3%
MRNA return
+159.5%
Excess return
-99.2%
Maximum drawdown
-26.0%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 3y.

Portfolio and benchmark returns by period
PeriodPortfolioMRNAExcessAlpha
1D-2.2%+1.3%-3.5%-2.2%
7D-3.6%-13.8%+10.3%-3.4%
30D-6.6%-17.7%+11.1%-6.4%
3M-7.4%+14.3%-21.7%-7.6%
6M+1.8%+336.0%-334.2%-2.2%
YTD+14.6%+575.9%-561.3%+8.4%
1Y+21.5%+724.4%-702.8%+14.1%
All+60.3%+159.5%-99.2%+52.1%

Cumulative growth

Daily Returns

Daily percentage return beside MRNA.

Daily Out/Under-Performance

Portfolio return minus MRNA return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × MRNA return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 3y: compounded portfolio wealth divided by compounded MRNA wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

3y analysis · Full analysis span regression · 6 months rolling